Similar articles

• [Value of the therapeutic sequence calcitonin-EHDP in Paget's disease].

  Eisinger J, Schiano A, d'Omezon Y, Ouaniche J. Eisinger J, et al. Rev Rhum Mal Osteoartic. 1983 Mar;50(3):245-6. Rev Rhum Mal Osteoartic. 1983. PMID: 6408727 French. No abstract available.
• [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].

  Ghiringhelli G, Fogel M, Varela de Rodríguez J, Casco C, Mautelén C, Nusimovich B. Ghiringhelli G, et al. Medicina (B Aires). 1982;42(1):16-20. Medicina (B Aires). 1982. PMID: 6813634 Spanish. No abstract available.
• [Therapy of Paget's disease of bone].

  Ziegler R, Frank K. Ziegler R, et al. Dtsch Med Wochenschr. 1988 Jan 22;113(3):102-5. doi: 10.1055/s-2008-1067602. Dtsch Med Wochenschr. 1988. PMID: 3123193 German. No abstract available.
• Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).

  Rashid M, Khairi A, Johnston C Jr. Rashid M, et al. Clin Orthop Relat Res. 1977;(127):94-105. Clin Orthop Relat Res. 1977. PMID: 410576 Review. No abstract available.
• Calcitonin and diphosphonate in the treatment of Paget's disease of bone.

  Hosking DJ. Hosking DJ. Metab Bone Dis Relat Res. 1981;3(4-5):317-26. doi: 10.1016/0221-8747(81)90048-5. Metab Bone Dis Relat Res. 1981. PMID: 6820113 Review.